Bone Biologics (BBLG) Gains from Investment Securities (2016 - 2017)
Historic Gains from Investment Securities for Bone Biologics (BBLG) over the last 2 years, with Q3 2017 value amounting to $412531.0.
- Bone Biologics' Gains from Investment Securities fell 9351.55% to $412531.0 in Q3 2017 from the same period last year, while for Sep 2017 it was $412531.0, marking a year-over-year decrease of 9351.55%. This contributed to the annual value of $1603.0 for FY2019, which is 728.74% down from last year.
- According to the latest figures from Q3 2017, Bone Biologics' Gains from Investment Securities is $412531.0, which was down 9351.55% from $8.6 million recorded in Q2 2017.
- In the past 5 years, Bone Biologics' Gains from Investment Securities registered a high of $12.7 million during Q1 2017, and its lowest value of -$502.0 during Q4 2016.